Phase III, Placebo-Controlled Trial of Three Doses of Citalopram for the Treatment of Hot Flashes: NCCTG Trial N05C9

PURPOSE: Up to 75% of women experience hot flashes, which can negatively impact quality of life. As hot flash physiology is not definitively understood, it cannot be assumed that effective agents represent class effects. Therefore, there is a continued need for rigorous evaluation to identify effect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Barton, Debra L., LaVasseur, Beth I., Sloan, Jeff A., Stawis, Allen N., Flynn, Kathleen A., Dyar, Missy, Johnson, David B., Atherton, Pamela J., Diekmann, Brent, Loprinzi, Charles L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903326/
https://ncbi.nlm.nih.gov/pubmed/20498389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.6379
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados